Annual EBIT
-$231.97M$183.06M+44.11%
Summary
- Current Value
- As of today, NVAX annual EBIT is -$231.97M, up +44.11% on
- Historical Performance
- NVAX annual EBIT is up +86.25% over the past 3 years, and down -78.99% over the past 5 years
- All-Time High Comparison
- NVAX annual EBIT is currently -4980.38% below its historical high of -$4.57M set on
- 3-Year Low Comparison
- NVAX annual EBIT is +64.02% above its 3-year low of -$644.74M reached on an earlier date
- Sector Comparison
- NVAX annual EBIT is higher than 7.11% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$231.97M | +44.1% | +86.3% | -79.0% | -520.5% | |
| Quarterly EBIT | -$79.40M | +38.8% | +37.6% | +58.9% | -653.4% | |
| TTM EBIT | $416.73M | +243.7% | +134.0% | +260.3% | +1013.6% | |
| Price | $7.78 | -9.0% | -36.7% | -93.9% | -84.5% | |
| PE Ratio | 4.40 | – | – | – | – | |
| Annual Revenue | $682.16M | -30.6% | -40.5% | +3555.3% | +10000.0% | |
| Annual EPS | -$1.23 | +77.2% | +94.7% | +77.6% | +86.3% | |
| Annual EBITDA | -$183.47M | +50.9% | +89.0% | -48.2% | -407.0% | |
| Annual Net Income | -$187.50M | +65.6% | +89.3% | -41.3% | -388.6% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$231.97M | at high | |
| 5Y | -$231.97M | at high | |
| All | -$4.57M | -4980.4% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$644.74M | N/A | +64.0% |
| 5Y | -$1.69B | +86.3% | |
| All | -$1.69B | +86.3% |
EBIT History
FAQ
What is the current annual EBIT of NVAX?
As of today, NVAX annual EBIT is -$231.97M
What is 1-year change in NVAX annual EBIT?
NVAX annual EBIT is up +44.11% year-over-year
What is 3-year change in NVAX annual EBIT?
NVAX annual EBIT is up +86.25% over the past 3 years
How far is NVAX annual EBIT from its all-time high?
NVAX annual EBIT is currently -4980.38% below its historical high of -$4.57M set on December 31, 1999
How does NVAX annual EBIT rank versus sector peers?
NVAX annual EBIT is higher than 7.11% of companies in Healthcare sector
When is NVAX next annual earnings release?
The next annual earnings release for NVAX is on
Quarterly EBIT
-$79.40M$185.07M-175.14%
Summary
- Current Value
- As of today, NVAX quarterly EBIT is -$79.40M, down -175.14% on
- Historical Performance
- NVAX quarterly EBIT is up +38.81% year-over-year, and up +37.57% over the past 3 years
- All-Time High Comparison
- NVAX quarterly EBIT is currently -115.39% below its historical high of $516.02M set on
- 3-Year Low Comparison
- NVAX quarterly EBIT is +74.61% above its 3-year low of -$312.77M reached on
- Sector Comparison
- NVAX quarterly EBIT is higher than 4.82% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$79.40M | -175.1% | +38.8% | +37.6% | +58.9% | |
| Annual EBIT | -$231.97M | – | +44.1% | +86.3% | -79.0% | |
| TTM EBIT | $416.73M | +13.8% | +243.7% | +134.0% | +260.3% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| PE Ratio | 4.40 | -12.7% | – | – | – | |
| Quarterly Revenue | $70.45M | -70.5% | -16.6% | -90.4% | -55.1% | |
| Quarterly EPS | -$1.25 | -307.4% | -64.5% | +42.1% | +61.1% | |
| Quarterly EBITDA | -$72.82M | -164.3% | +37.8% | +38.7% | +62.1% | |
| Quarterly Net Income | -$202.38M | -290.0% | -66.8% | -20.0% | -2.6% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $516.02M | -115.4% | |
| 3Y | $516.02M | -115.4% | |
| 5Y | $516.02M | -115.4% | |
| All | $516.02M | -115.4% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$125.55M | N/A | +36.8% |
| 3Y | -$312.77M | +74.6% | |
| 5Y | -$824.97M | +90.4% | |
| All | -$824.97M | +90.4% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of NVAX?
As of today, NVAX quarterly EBIT is -$79.40M
What is NVAX quarterly EBIT most recent change?
NVAX quarterly EBIT was down -175.14% on September 30, 2025
What is 1-year change in NVAX quarterly EBIT?
NVAX quarterly EBIT is up +38.81% year-over-year
How far is NVAX quarterly EBIT from its all-time high?
NVAX quarterly EBIT is currently -115.39% below its historical high of $516.02M set on March 31, 2025
How does NVAX quarterly EBIT rank versus sector peers?
NVAX quarterly EBIT is higher than 4.82% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
TTM EBIT
$416.73M$50.37M+13.75%
Summary
- Current Value
- As of today, NVAX TTM EBIT is $416.73M, up +13.75% on
- Historical Performance
- NVAX TTM EBIT is up +243.72% year-over-year, and up +134.00% over the past 3 years
- All-Time High Comparison
- NVAX TTM EBIT is currently -1.44% below its historical high of $422.81M set on
- 3-Year Low Comparison
- NVAX TTM EBIT is +135.72% above its 3-year low of -$1.17B reached on
- Sector Comparison
- NVAX TTM EBIT is higher than 91.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | $416.73M | +13.8% | +243.7% | +134.0% | +260.3% | |
| Annual EBIT | -$231.97M | – | +44.1% | +86.3% | -79.0% | |
| Quarterly EBIT | -$79.40M | -175.1% | +38.8% | +37.6% | +58.9% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| PE Ratio | 4.40 | -12.7% | – | – | – | |
| TTM Revenue | $1.06B | -1.3% | +20.3% | -42.4% | +420.0% | |
| TTM EPS | $1.77 | -21.6% | +178.3% | +110.2% | +133.9% | |
| TTM EBITDA | $451.74M | +10.9% | +285.8% | +137.6% | +276.5% | |
| TTM Net Income | $341.75M | -19.2% | +220.0% | +125.8% | +225.4% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $422.81M | -1.4% | |
| 3Y | $422.81M | -1.4% | |
| 5Y | $422.81M | -1.4% | |
| All | $422.81M | -1.4% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$231.94M | N/A | +279.7% |
| 3Y | -$1.17B | +135.7% | |
| 5Y | -$1.69B | +124.7% | |
| All | -$1.69B | +124.7% |
TTM EBIT History
FAQ
What is the current TTM EBIT of NVAX?
As of today, NVAX TTM EBIT is $416.73M
What is NVAX TTM EBIT most recent change?
NVAX TTM EBIT was up +13.75% on September 30, 2025
What is 1-year change in NVAX TTM EBIT?
NVAX TTM EBIT is up +243.72% year-over-year
How far is NVAX TTM EBIT from its all-time high?
NVAX TTM EBIT is currently -1.44% below its historical high of $422.81M set on March 31, 2025
How does NVAX TTM EBIT rank versus sector peers?
NVAX TTM EBIT is higher than 91.61% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
EBIT Formula
EBIT = − −
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069425000046/0001000694-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069425000004/0001000694-25-000004-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax